GuiZhou SanLi Pharmaceutical Co.,Ltd

Shanghai Stock Exchange 603439.SS

GuiZhou SanLi Pharmaceutical Co.,Ltd Total Assets for the year ending December 31, 2023: USD 411.35 M

GuiZhou SanLi Pharmaceutical Co.,Ltd Total Assets is USD 411.35 M for the year ending December 31, 2023, a 56.26% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.

GuiZhou SanLi Pharmaceutical Co.,Ltd Total Assets for the year ending December 31, 2022 was USD 263.25 M, a 19.05% change year over year.
GuiZhou SanLi Pharmaceutical Co.,Ltd Total Assets for the year ending December 31, 2021 was USD 221.12 M, a 14.66% change year over year.
GuiZhou SanLi Pharmaceutical Co.,Ltd Total Assets for the year ending December 31, 2020 was USD 192.85 M, a 83.76% change year over year.
GuiZhou SanLi Pharmaceutical Co.,Ltd Total Assets for the year ending December 31, 2019 was USD 104.94 M, a 25.15% change year over year.

Key data

Date	Total Assets	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity

Shanghai Stock Exchange: 603439.SS

GuiZhou SanLi Pharmaceutical Co.,Ltd

CEO	Mr. Hai Zhang
IPO Date	April 28, 2020
Location	China
Headquarters	Xiayun Industrial Park
Employees	2,282
Sector	Health Care
Industries Pharmaceuticals

Description

GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products. It offers pediatric medication, respiratory system medication, cardiovascular and cerebrovascular drugs, digestive medicine, trauma injury medication, rehabilitation medicine, and ophthalmic medicine. The company was founded in 1995 and is based in Guiyang, China.

Key trends

Past 5 years